Trident Texofab Ltd. benchmarking: Performance to industry peers

Financial

	Trident Texofab	Vinny Overseas	Signoria Creation
Operational Metrics
Financials
5 yr Average ROE	7.4 %	5.51 %	30.78 %
5yr average Equity Multiplier	4.68	2.15	4.32
5yr Average Asset Turnover Ratio	1.12	1.62	0.86
5yr Avg Net Profit Margin	1.46 %	1.17 %	9.36 %
Price to Book	0.92	0.61	0.0
P/E	72.02	55.51	13.35
5yr Avg Cash Conversion Cycle	104.45 Days	-91.43 Days	142.68 Days
Inventory Days	44.03 Days	44.82 Days	120.27 Days
Days Receivable	115.01 Days	52.63 Days	178.49 Days
Days Payable	80.92 Days	157.88 Days	265.11 Days
5yr Average Interest Coverage Ratio	1.47	2.66	4.64
5yr Avg ROCE	12.2 %	6.28 %	23.43 %
5yr Avg Operating Profit Margin	5.78 %	4.63 %	17.19 %
5 yr average Debt to Equity	2.09	0.49	1.66
5yr CAGR Net Profit	47.58 %	67.55 %	55.7 %
5yr Average Return on Assets	1.71 %	1.29 %	7.44 %
Shareholdings
Promoter Holding	32.16 %	39.27 %	70.05 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-29.07 %	-32.6 %	0.06 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0